查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600951

免疫檢測市場：按產品、技術、檢體、適應症和最終用戶分類 - 全球預測 2025-2030 年

Immunoassay Market by Product (Analyzer, Consumables), Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay), Specimen, Indication, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年免疫檢測市場估值為263億美元，預計2024年將達282.9億美元，預計複合年成長率為7.24%，到2030年將達429億美元。

免疫檢測是透過抗原-抗體相互作用來測量分子的存在或濃度的生化測試。它在診斷、藥物分析和生化研究中發揮著重要作用。免疫測量的需求源於對準確、快速診斷解決方案日益成長的需求，特別是在臨床診斷、環境監測和食品安全檢測領域。免疫測量具有廣泛的用途，包括疾病診斷、治療藥物監測和懷孕檢測。最終用途包括醫院、實驗室、生技公司等。免疫檢測市場受到技術進步、慢性病盛行率增加以及疾病早期檢測意識增強等因素的影響。新的機會包括整合人工智慧和機器學習以增強資料解釋、擴大即時檢測 (POCT) 以及開發多重檢測以同時檢測多種分析物。創新可以集中在可攜式和易於使用的設備、提高通量的自動化以及提高檢測靈敏度和特異性。然而，市場成長面臨挑戰，例如先進檢測解決方案的高成本、嚴格的監管標準以及檢測性能可能存在的技術限制。此外，交叉反應和基質干擾等問題也會影響測定的準確性。成功克服這些挑戰需要對研發進行策略性投資，以實現穩健的檢測開發，並具有向診斷工具需求迅速成長的新興經濟體擴張的潛力。創新研究領域包括生物感測器、微流體和奈米技術，以提高分析性能和效率。免疫檢測市場是一個競爭激烈的市場，其特點是不斷創新和夥伴關係以擴大產品供應。公司必須專注於實施簡化工作流程並提供強大客戶支援的新技術。利用與研究機構和醫療保健提供者的合作可以推動創新和市場滲透，使您的公司處於滿足不斷變化的醫療保健需求的最前沿。

主要市場統計
基準年[2023] 263億美元
預測年份 [2024] 282.9億美元
預測年份 [2030] 429億美元
複合年成長率（%） 7.24%

市場動態：揭示快速發展的免疫檢測市場的關鍵市場洞察

供需的動態交互作用正在改變免疫檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病和感染疾病的增加以及早期診斷的好處
    • 擴大免疫檢測在食品和飲料領域的應用
    • 多重檢測免疫檢測技術在藥物研發的新應用
  • 市場限制因素
    • 與免疫檢測相關的交叉反應問題
  • 市場機會
    • 與免疫檢測相關的自動化設備和儀器數量的技術進步
    • 免疫檢測在環境監測中的巨大潛力
  • 市場問題
    • 由於樣品品質和試劑性能的變化而導致的測定驗證問題

波特五力：駕馭免疫檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解免疫檢測市場的外部影響

外部宏觀環境因素在塑造免疫檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解免疫檢測市場的競爭格局

對免疫檢測市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣免疫檢測市場供應商的績效評估

FPNV定位矩陣是評估免疫檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃免疫檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對免疫檢測市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和感染疾病的增加以及早期診斷的好處
      • 免疫檢測在食品和飲料行業的使用增加
      • 多重檢測技術在藥物研發的新應用
    • 抑制因素
      • 與免疫檢測相關的交叉反應問題
    • 機會
      • 與免疫檢測相關的自動化儀器和設備數量的技術進步
      • 免疫檢測在環境監測中的巨大潛力
    • 任務
      • 由於樣品品質和試劑性能的變化而導致的測定檢驗問題
  • 市場區隔分析
    • 產品：開發用於診斷感染疾病和自體免疫疾病的新型免疫檢測套件
    • 技術：利用酵素結合免疫吸附測定技術治療食物過敏和藥物濫用
    • 檢體：使用非侵入性採集方法進行唾液診斷的出現
    • 適應症：最佳化免疫檢測技術以滿足感染疾病整體成長的需求
    • 最終用戶：急診醫學、加護病房和門診診所對免疫檢測的需求正在增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章免疫檢測市場：依產品

  • 分析儀
  • 消耗品
    • 檢測試劑套件
    • 孔盤和管
    • 試劑

第7章免疫檢測市場：依技術分類

  • 化學冷光免疫檢測
  • 酵素免疫分析法
  • 螢光免疫分析
  • 免疫檢測
  • 快速診斷測試 (RDT)/側流免疫檢測

第8章免疫檢測市場（按樣本）

  • 血
  • 唾液
  • 尿

第9章按適應症分類的免疫檢測市場

  • 心臟病學
  • 內分泌學
  • 感染疾病
  • 腫瘤學
  • 整形外科

第 10 章免疫檢測市場：依最終使用者分類

  • 血庫
  • 診斷實驗室
  • 食品和飲料公司
  • 醫院
  • 製藥公司和 CRO
  • 研究/學術機構

第11章：美洲免疫檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太免疫檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的免疫檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Thermo Fisher 斥資 31 億美元收購 Olink，擴大蛋白質體學業務
    • FUJIREBIO和 Sysmex 合作開發獨特的免疫檢測方法
    • 邁瑞同意收購德國 Diasys 診斷系統公司 75% 的股份
    • CVC基金「島津未來創新基金」投資了開發免疫檢測技術的IMMUNOSENS Co., Ltd.。
    • Fapon推出新型化學冷光免疫檢測系統
    • Beckman Coulter 的 DxI 9000免疫檢測分析儀具有改進的分析開發靈敏度，在 2023 年 AACC 北美首次亮相
    • 貝克曼庫爾特 (Beckman Coulter) 和FUJIREBIO合作，增強患者友善血液阿茲海默症檢測的可及性
    • Makati Med 成為菲律賓和東協第一家購買 Atelica VTLi 病患側免疫檢測分析儀的醫院
    • QuidelOrtho Sofia 2 SARS 抗原+FIA 獲得 FDA De Novo 批准
    • SGS 在普瓦捷實驗室提供增強型自動化免疫檢測測試
    • 西門子建立免疫檢測儀器研發卓越中心
  • 戰略分析和建議

公司名單

  • HU Group Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Siemens Healthineers AG
  • Tosoh Corporation
  • Merck KGaA
  • Gyros Protein Technologies AB
  • MiCo BioMed, Inc.
  • OPKO Health, Inc.
  • Promega Corporation
  • BioLegend, Inc.
  • Epitope Diagnostics Inc.
  • Dynex Technologies, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Tecan Trading AG
  • NanoEntek
  • Zoetis Inc.
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Boditech Med Inc.
  • Thermo Fisher Scientific Inc.
  • Nanomix, Inc.
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Quanterix Corporation
  • ANP Technologies, Inc.
  • Diasorin SpA
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Randox Laboratories Ltd.
  • Abbott Laboratories
  • Sysmex Corporation
  • Almac Group Limited
  • Biosurfit SA
  • Bio-Techne Corporation
  • Koninklijke Philips NV
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson, and Company
  • Agilent Technologies Inc.
  • Kamiya Biomedical Company
  • QIAGEN NV
  • Fapon Biotech Inc.
  • WAK-Chemie Medical GmbH
  • Zybio Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Autobio Diagnostics Co., Ltd.
Product Code: MRR-43127F7279BC

The Immunoassay Market was valued at USD 26.30 billion in 2023, expected to reach USD 28.29 billion in 2024, and is projected to grow at a CAGR of 7.24%, to USD 42.90 billion by 2030.

An immunoassay is a biochemical test that measures the presence or concentration of a molecule through an antigen-antibody interaction. It plays an essential role in diagnostics, pharmaceutical analysis, and biochemical research. The necessity for immunoassays arises from the growing demand for accurate and rapid diagnostic solutions, especially in clinical diagnostics, environmental monitoring, and food safety testing. Their application encompasses disease diagnosis, therapeutic drug monitoring, and pregnancy testing, among others. End-use segments include hospitals, research laboratories, and biotechnology firms. The immunoassay market is influenced by factors such as technological advancements, a rising prevalence of chronic diseases, and increasing awareness of early disease detection. Emerging opportunities include the integration of AI and machine learning for enhanced data interpretation, expanding Point-of-Care Testing (POCT), and the development of multiplex assays for simultaneously detecting multiple analytes. Innovation can focus on portable and user-friendly devices, automation to enhance throughput, and improved assay sensitivity and specificity. However, market growth faces challenges like high costs of advanced assay solutions, stringent regulatory standards, and possible technical limitations in assay performance. Additionally, issues such as cross-reactivity and matrix interference can affect assay accuracy. Successful navigation of these challenges requires strategic investment in R&D for robust assay development and potential expansion into developing economies where demand for diagnostic tools is burgeoning. Innovative areas for exploration include biosensors, microfluidics, and nanotechnology to enhance assay performance and efficiency. The immunoassay market is competitive and characterized by continuous technological innovation and partnerships to expand product offerings. Companies must focus on deploying newer technologies that streamline workflows and offer strong customer support. Leveraging collaborations with research institutes and healthcare providers can foster innovation and market penetration, placing businesses at the forefront of meeting evolving healthcare demands.

KEY MARKET STATISTICS
Base Year [2023] USD 26.30 billion
Estimated Year [2024] USD 28.29 billion
Forecast Year [2030] USD 42.90 billion
CAGR (%) 7.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoassay Market

The Immunoassay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising chronic and infectious diseases and benefits of early diagnosis
    • Growing usage of immunoassay in the food & beverage sector
    • Emerging application of multiplex detection immunoassay technique in drug development
  • Market Restraints
    • Cross-reactivity issues associated with immunoassay
  • Market Opportunities
    • Technological advancements in the number of automated instruments and equipment associated with immunoassay
    • High potential of immunoassay in environment monitoring
  • Market Challenges
    • Issues with assay validation due to variations in sample quality and reagent performance

Porter's Five Forces: A Strategic Tool for Navigating the Immunoassay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoassay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoassay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoassay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoassay Market

A detailed market share analysis in the Immunoassay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoassay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoassay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoassay Market

A strategic analysis of the Immunoassay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoassay Market, highlighting leading vendors and their innovative profiles. These include H.U. Group Holdings Inc., Charles River Laboratories International, Inc., Siemens Healthineers AG, Tosoh Corporation, Merck KGaA, Gyros Protein Technologies AB, MiCo BioMed, Inc., OPKO Health, Inc., Promega Corporation, BioLegend, Inc., Epitope Diagnostics Inc., Dynex Technologies, Inc., Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Tecan Trading AG, NanoEntek, Zoetis Inc., Shenzhen Micropoint Biotechnologies Co., Ltd., Boditech Med Inc., Thermo Fisher Scientific Inc., Nanomix, Inc., bioMerieux S.A., QuidelOrtho Corporation, Quanterix Corporation, ANP Technologies, Inc., Diasorin S.p.A., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Randox Laboratories Ltd., Abbott Laboratories, Sysmex Corporation, Almac Group Limited, Biosurfit SA, Bio-Techne Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Becton, Dickinson, and Company, Agilent Technologies Inc., Kamiya Biomedical Company, QIAGEN N.V., Fapon Biotech Inc., WAK-Chemie Medical GmbH, Zybio Inc., J. Mitra & Co. Pvt. Ltd., and Autobio Diagnostics Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Immunoassay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analyzer and Consumables. The Consumables is further studied across Assay Kits, Microwell Plates & Tubes, and Reagents.
  • Based on Technology, market is studied across Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Fluoroimmunoassay, Radioimmunoassay, and Rapid Diagnostic Tests (RDTs)/Lateral Flow Immunoassay.
  • Based on Specimen, market is studied across Blood, Saliva, and Urine.
  • Based on Indication, market is studied across Cardiology, Endocrinology, Infectious Disease, Oncology, and Orthopedics.
  • Based on End User, market is studied across Blood Banks, Diagnostics Laboratories, Food & Beverage Companies, Hospitals, Pharmaceutical Companies & CROs, and Research & Academic Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising chronic and infectious diseases and benefits of early diagnosis
      • 5.1.1.2. Growing usage of immunoassay in the food & beverage sector
      • 5.1.1.3. Emerging application of multiplex detection immunoassay technique in drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Cross-reactivity issues associated with immunoassay
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the number of automated instruments and equipment associated with immunoassay
      • 5.1.3.2. High potential of immunoassay in environment monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Issues with assay validation due to variations in sample quality and reagent performance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Development of novel immunoassay kits for diagnostics of infectious and autoimmune diseases
    • 5.2.2. Technology: Utilization of enzyme-linked immunosorbent assay technology for food allergies and drugs of abuse treatment
    • 5.2.3. Specimen: Emergence of saliva diagnostics due to its non-invasive collection methods
    • 5.2.4. Indication: Optimization within immunoassay technologies to cater growing need across infectious disease
    • 5.2.5. End User: Rising demand for immunoassay across emergency care, intensive care units, and outpatient clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoassay Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzer
  • 6.3. Consumables
    • 6.3.1. Assay Kits
    • 6.3.2. Microwell Plates & Tubes
    • 6.3.3. Reagents

7. Immunoassay Market, by Technology

  • 7.1. Introduction
  • 7.2. Chemiluminescence Immunoassay
  • 7.3. Enzyme-linked Immunosorbent Assay
  • 7.4. Fluoroimmunoassay
  • 7.5. Radioimmunoassay
  • 7.6. Rapid Diagnostic Tests (RDTs)/Lateral Flow Immunoassay

8. Immunoassay Market, by Specimen

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Saliva
  • 8.4. Urine

9. Immunoassay Market, by Indication

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Endocrinology
  • 9.4. Infectious Disease
  • 9.5. Oncology
  • 9.6. Orthopedics

10. Immunoassay Market, by End User

  • 10.1. Introduction
  • 10.2. Blood Banks
  • 10.3. Diagnostics Laboratories
  • 10.4. Food & Beverage Companies
  • 10.5. Hospitals
  • 10.6. Pharmaceutical Companies & CROs
  • 10.7. Research & Academic Laboratories

11. Americas Immunoassay Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Immunoassay Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Immunoassay Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Thermo Fisher to Acquire Olink for USD 3.1 billion, Expanding Proteomics Presence
    • 14.3.2. Fujirebio and Sysmex to Collaborate On Development of Unique Immunoassays
    • 14.3.3. Mindray Has Agreed to Acquire 75% Stake in Germany-Based DiaSys Diagnostic Systems GmbH
    • 14.3.4. CVC Fund "Shimadzu Future Innovation Fund" has Invested in IMMUNOSENS Co., Ltd., Developing Immunoassay Technology.
    • 14.3.5. Fapon Rolls Out New Chemiluminescence Immunoassay System
    • 14.3.6. Beckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
    • 14.3.7. Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer's Disease Test
    • 14.3.8. MakatiMed First PH and ASEAN Hospital to Acquire Atellica VTLi Patient-Side Immunoassay Analyzer
    • 14.3.9. QuidelOrtho Receives De Novo FDA Authorization for Sofia 2 SARS Antigen+ FIA
    • 14.3.10. SGS Offers Enhanced Automated Immunoassay Testing at Poitiers Laboratory
    • 14.3.11. Siemens launches Centre of Excellence for Immunoassay Instrument R&D
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. H.U. Group Holdings Inc.
  • 2. Charles River Laboratories International, Inc.
  • 3. Siemens Healthineers AG
  • 4. Tosoh Corporation
  • 5. Merck KGaA
  • 6. Gyros Protein Technologies AB
  • 7. MiCo BioMed, Inc.
  • 8. OPKO Health, Inc.
  • 9. Promega Corporation
  • 10. BioLegend, Inc.
  • 11. Epitope Diagnostics Inc.
  • 12. Dynex Technologies, Inc.
  • 13. Danaher Corporation
  • 14. PerkinElmer, Inc.
  • 15. Bio-Rad Laboratories, Inc.
  • 16. Tecan Trading AG
  • 17. NanoEntek
  • 18. Zoetis Inc.
  • 19. Shenzhen Micropoint Biotechnologies Co., Ltd.
  • 20. Boditech Med Inc.
  • 21. Thermo Fisher Scientific Inc.
  • 22. Nanomix, Inc.
  • 23. bioMerieux S.A.
  • 24. QuidelOrtho Corporation
  • 25. Quanterix Corporation
  • 26. ANP Technologies, Inc.
  • 27. Diasorin S.p.A.
  • 28. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 29. Randox Laboratories Ltd.
  • 30. Abbott Laboratories
  • 31. Sysmex Corporation
  • 32. Almac Group Limited
  • 33. Biosurfit SA
  • 34. Bio-Techne Corporation
  • 35. Koninklijke Philips N.V.
  • 36. F. Hoffmann-La Roche Ltd.
  • 37. Becton, Dickinson, and Company
  • 38. Agilent Technologies Inc.
  • 39. Kamiya Biomedical Company
  • 40. QIAGEN N.V.
  • 41. Fapon Biotech Inc.
  • 42. WAK-Chemie Medical GmbH
  • 43. Zybio Inc.
  • 44. J. Mitra & Co. Pvt. Ltd.
  • 45. Autobio Diagnostics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. IMMUNOASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROWELL PLATES & TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS)/LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IMMUNOASSAY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL IMMUNOASSAY MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL COMPANIES & CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES IMMUNOASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2023